Small-Cap Pharmaceutical Stock Surges 246% on Positive Data

Never ignore a stock just because it appears to be down-and-out. You may just miss a triple-digit profit opportunity. Axsome Therapeutics (AXSM) is a great example. Axsome Therapeutics is a clinical-stage biopharmaceutical company that develops therapies for the management of central nervous system (CNS) disorders. The Company’s product candidates include AXS-05, which is in Phase…

Congress Votes to Legalize Industrial Hemp: What it Means for Investors

Thanks to growing acceptance, including Canada’s October 2018 legalization, approval for medicinal and recreational usage across the U.S., and growing interest from corporate America, cannabis has become a booming business. Now, there’s potential for even more explosive growth after Congress approved an $867 billion farm bill with a vote of 386-47 in the House and…